1E Pharma Solutions

At 1E Therapeutics, we specialize in supporting the next generation of RNA and DNA-based therapeutics through end-to-end CDMO services. From custom oligonucleotide synthesis to GMP drug substance manufacturing and aseptic fill & finish, we deliver high-quality, scalable solutions tailored to your program’s needs. Whether you’re developing siRNA, ASOs, ssDNA, or other nucleic acid-based therapies, our platform enables a broad range of modifications, conjugations, and delivery formats — all backed by deep technical expertise and a flexible, responsive approach. We serve biotech and pharmaceutical companies advancing nucleic acid drugs toward clinical and commercial milestones — with a commitment to precision, speed, and scientific partnership. Let’s move your molecule forward, faster.